245 related articles for article (PubMed ID: 32380376)
21. Challenges to epilepsy management in Rwandan women living with epilepsy.
Teuwen DE; Ndayisenga A; Garrez I; Sebera F; Mutungirehe S; Umwiringirwa J; Ndiaye M; Umuhoza G; Boon PAJM; Dedeken P
Eur J Neurol; 2024 Jun; 31(6):e16254. PubMed ID: 38429893
[TBL] [Abstract][Full Text] [Related]
22. The prescribing of antiepileptic drugs for pregnant Australian women.
Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
[TBL] [Abstract][Full Text] [Related]
23. Real-world prescribing trends of valproate in women with epilepsy in Korea.
Han SH; Lee H; Shin JY; Moon HJ; Lee SY
Epilepsy Behav; 2021 Feb; 115():107700. PubMed ID: 33421853
[TBL] [Abstract][Full Text] [Related]
24. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
[TBL] [Abstract][Full Text] [Related]
25. The preconception care experiences of women with epilepsy on sodium valproate.
Lawther L; Dolk H; Sinclair M; Morrow J
Seizure; 2018 Jul; 59():82-89. PubMed ID: 29778017
[TBL] [Abstract][Full Text] [Related]
26. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
Perera C; Patterson S; Bruxner G
Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
[TBL] [Abstract][Full Text] [Related]
27. Valproate prescribing practices for women with intellectual disability across Europe.
Watkins L; Reuber M; Perera B; Courtenay K; Banks R; Murphy E; Angus-Leppan H; Shankar R
Acta Neurol Scand; 2021 Jan; 143(1):56-61. PubMed ID: 32813274
[TBL] [Abstract][Full Text] [Related]
28. Hormonal contraception in patients with epilepsy.
Bosak M; Cyranka K; Slowik A
Ginekol Pol; 2019; 90(2):61-65. PubMed ID: 30860270
[TBL] [Abstract][Full Text] [Related]
29. Prescribing trends for sodium valproate in Ireland.
Murphy S; Bennett K; Doherty CP
Seizure; 2016 Mar; 36():44-48. PubMed ID: 26896815
[TBL] [Abstract][Full Text] [Related]
30. Valproate and epilepsy: for women as well as men.
Lawthom C
Pract Neurol; 2018 Jun; 18(3):222-223. PubMed ID: 29686036
[TBL] [Abstract][Full Text] [Related]
31. Valproate: life-saving, life-changing.
Thomas RH
Clin Med (Lond); 2018 Apr; 18(Suppl 2):s1-s8. PubMed ID: 29700085
[TBL] [Abstract][Full Text] [Related]
32. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
33. Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study.
Cohen MJ; Meador KJ; May R; Loblein H; Conrad T; Baker GA; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
Epilepsy Behav; 2019 Mar; 92():154-164. PubMed ID: 30660966
[TBL] [Abstract][Full Text] [Related]
34. Valproate utilisation trends among girls and women from 2013 to 2018.
Puteikis K; Medžiaušaitė I; Mameniškienė R
Seizure; 2019 Aug; 70():77-81. PubMed ID: 31310965
[TBL] [Abstract][Full Text] [Related]
35. Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome.
Cerulli Irelli E; Morano A; Cocchi E; Casciato S; Fanella M; Albini M; Avorio F; Basili LM; Fisco G; Barone FA; Mascia A; D'Aniello A; Manfredi M; Fattouch J; Quarato P; Giallonardo AT; Di Gennaro G; Di Bonaventura C
Epilepsia; 2020 Jan; 61(1):107-114. PubMed ID: 31828782
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
[TBL] [Abstract][Full Text] [Related]
37. Valproate prescriptions for nonepilepsy disorders in reproductive-age women.
Adedinsewo DA; Thurman DJ; Luo YH; Williamson RS; Odewole OA; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2013 Jun; 97(6):403-8. PubMed ID: 23733498
[TBL] [Abstract][Full Text] [Related]
38. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855
[TBL] [Abstract][Full Text] [Related]
39. Impact of recommendations on sodium valproate prescription among women with epilepsy: An interrupted time-series study.
Degremont A; Polard E; Kerbrat S; Grimaud O; Jonville-Béra AP; Ringa V; Travers D; Oger E; Biraben A; Nowak E
Epilepsy Behav; 2021 Dec; 125():108449. PubMed ID: 34839242
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
